BRIAN POLIQUIN: Open Payments
NPI 1881836286 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,320 in 66 payments from 17 companies in 2025. Trend: 2023 $733 · 2024 $1,191 · 2025 $1,320
Food & beverage: $1,320
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $339 |
| Novo Nordisk Inc | 15 | $271 |
| AstraZeneca Pharmaceuticals LP | 2 | $170 |
| Exact Sciences Corporation | 4 | $75 |
| PFIZER INC. | 3 | $58 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $56 |
| Lilly USA, LLC | 3 | $55 |
| Amgen Inc. | 3 | $54 |
| Abbott Laboratories | 2 | $42 |
| GlaxoSmithKline, LLC. | 2 | $41 |
Products named: VRAYLAR, UBRELVY, Wegovy, Ozempic, Kerendia, Rybelsus, BREZTRI, FREESTYLE LIBRE 3.
Industry payments across TX — which companies pay providers there.
